These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11808819)

  • 1. Carbamazepine decreases antihypertensive effect of nilvadipine.
    Yasui-Furukori N; Tateishi T
    J Clin Pharmacol; 2002 Jan; 42(1):100-3. PubMed ID: 11808819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nilvadipine: profile of a new calcium antagonist. An overview.
    Rosenthal J
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S92-107. PubMed ID: 7898101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How long does the pharmacokinetic interaction between carbamazepine and quetiapine last after carbamazepine withdrawal?
    Kopecek M; Potmesil P
    Neuro Endocrinol Lett; 2017 Dec; 38(7):475-478. PubMed ID: 29369597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tolerability of nilvadipine compared to nifedipine in patients with essential hypertension.
    Faust G
    J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S56-61. PubMed ID: 1283191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nilvadipine increases cerebral blood flow in elderly hypertensives: comparison with nifedipine.
    Shimamoto H; Shimamoto Y
    J Hum Hypertens; 1995 Apr; 9(4):271-9. PubMed ID: 7595910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 24-hour blood pressure control after single daily doses of nivaldipine in patients with essential hypertension.
    Lossnitzer K; Huber HJ; Kuchlbauer R; Quitzdorff G
    J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S35-42. PubMed ID: 1283187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nilvadipine. A review of its pharmacodynamic and pharmacokinetic properties, therapeutic use in hypertension and potential in cerebrovascular disease and angina.
    Brogden RN; McTavish D
    Drugs Aging; 1995 Feb; 6(2):150-71. PubMed ID: 7711361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the clinical pharmacology of nilvadipine in patients with mild to moderate essential hypertension.
    Weir MR; Vlachkis ND; DeQuattro V; Douglas J; Svetkey LP; Singh S; Wiedl SC; Chen CF; Woodward DL; Saunders E
    J Clin Pharmacol; 1990 May; 30(5):425-37. PubMed ID: 2189903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of treatment with nilvadipine on cerebral ischemia in rats.
    Kawamura S; Li Y; Shirasawa M; Yasui N; Fukasawa H
    Tohoku J Exp Med; 1998 Aug; 185(4):239-46. PubMed ID: 9865470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced efficacy of nilvadipine in hypertensives whose raised ambulatory blood pressure is sustained during sleep.
    Yoshikawa H; Ohta A; Kasamatsu K; Ueno C; Funai H; Kuse S; Satani O; Nakamura N; Fukuda K; Hano T; Ueno Y; Nishio I; Iseki Y
    Am J Hypertens; 1998 Jan; 11(1 Pt 1):122-4. PubMed ID: 9504460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparisons of once-daily nilvadipine with enalapril and diuretic in patients with essential hypertension.
    Fritschka E
    J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S62-8. PubMed ID: 1283192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of nilvadipine and amlodipine in patients with mild to moderate essential hypertension: a double blind, prospective, randomised clinical trial.
    Leonetti G;
    Curr Med Res Opin; 2005 Jun; 21(6):951-8. PubMed ID: 15969895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships between pharmacokinetic parameters of carbamazepine and therapeutic response in patients with bipolar disease.
    Chbili C; Bannour S; Khlifi S; Ben Hadj Ali B; Saguem S
    Ann Biol Clin (Paris); 2014; 72(4):453-9. PubMed ID: 25119803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interindividual variation of plasma haloperidol concentrations and the impact of concomitant medications: the analysis of therapeutic drug monitoring data.
    Hirokane G; Someya T; Takahashi S; Morita S; Shimoda K
    Ther Drug Monit; 1999 Feb; 21(1):82-6. PubMed ID: 10051058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nilvadipine in hypertension with renal dysfunction.
    Berger HH; Albert FW
    J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S73-9. PubMed ID: 1283194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of nilvadipine.
    von Nieciecki A; Huber HJ; Stanislaus F
    J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S22-9. PubMed ID: 1283185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbamazepine-nefazodone interaction in healthy subjects.
    Laroudie C; Salazar DE; Cosson JP; Cheuvart B; Istin B; Girault J; Ingrand I; Decourt JP
    J Clin Psychopharmacol; 2000 Feb; 20(1):46-53. PubMed ID: 10653208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the efficacy of nilvadipine and nitrendipine on circadian blood pressure.
    Keck M
    J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S43-9. PubMed ID: 1283188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Deterioration of schizoaffective disorder due to an interaction between haloperidol and carbamazepine].
    Cohen D; Diemont WL
    Ned Tijdschr Geneeskd; 2002 Oct; 146(41):1942-4. PubMed ID: 12404911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A new cause of resistant arterial hypertension: coprescription with anticonvulsant treatments].
    Iaria P; Blacher J; Asplanato M; Edric K; Safar M; Girerd X
    Arch Mal Coeur Vaiss; 1999 Aug; 92(8):1005-8. PubMed ID: 10486655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.